688276 Stock Overview
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Changchun BCHT Biotechnology Co. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥26.36 |
| 52 Week High | CN¥58.50 |
| 52 Week Low | CN¥21.18 |
| Beta | 0.011 |
| 1 Month Change | -3.23% |
| 3 Month Change | 20.37% |
| 1 Year Change | -50.53% |
| 3 Year Change | -60.86% |
| 5 Year Change | n/a |
| Change since IPO | -77.76% |
Recent News & Updates
Recent updates
Market Might Still Lack Some Conviction On Changchun BCHT Biotechnology Co. (SHSE:688276) Even After 36% Share Price Boost
Oct 07
Analysts Just Slashed Their Changchun BCHT Biotechnology Co. (SHSE:688276) EPS Numbers
Aug 22Changchun BCHT Biotechnology Co. (SHSE:688276) Doing What It Can To Lift Shares
Jul 28Is Changchun BCHT Biotechnology (SHSE:688276) Using Too Much Debt?
Jun 19Changchun BCHT Biotechnology Co. (SHSE:688276) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless
Apr 16We Think That There Are Issues Underlying Changchun BCHT Biotechnology's (SHSE:688276) Earnings
Mar 30Shareholder Returns
| 688276 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -2.7% | -4.9% | -3.5% |
| 1Y | -50.5% | -17.6% | 10.9% |
Return vs Industry: 688276 underperformed the CN Biotechs industry which returned -17.6% over the past year.
Return vs Market: 688276 underperformed the CN Market which returned 10.9% over the past year.
Price Volatility
| 688276 volatility | |
|---|---|
| 688276 Average Weekly Movement | 9.4% |
| Biotechs Industry Average Movement | 8.8% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 688276 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688276's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 1,289 | Wei Kong | www.bchtpharm.com |
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company’s products include live herpes zoster vaccine; live varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and Rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd.
Changchun BCHT Biotechnology Co. Fundamentals Summary
| 688276 fundamental statistics | |
|---|---|
| Market cap | CN¥10.83b |
| Earnings (TTM) | CN¥414.29m |
| Revenue (TTM) | CN¥1.61b |
26.3x
P/E Ratio6.8x
P/S RatioIs 688276 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688276 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.61b |
| Cost of Revenue | CN¥220.26m |
| Gross Profit | CN¥1.39b |
| Other Expenses | CN¥972.96m |
| Earnings | CN¥414.29m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.00 |
| Gross Margin | 86.30% |
| Net Profit Margin | 25.77% |
| Debt/Equity Ratio | 1.5% |
How did 688276 perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield15%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 11:03 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Changchun BCHT Biotechnology Co. is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hangci Zheng | China International Capital Corporation Limited |
| Yizheng Yang | China International Capital Corporation Limited |
| Sophia Zhang | China Stock Investment Research Co. Ltd. (GZ500..com) |